Navigation Links
Painkiller Based on Sea Snail Venom Made Available in Britain

New painkiller, Prialt, based on the venom of a sea snail will be available in Britain from today.

The drug Prialt, or ziconotide, has resulted from over// 20 years' of research by the scientist, Baldomera Olivera, a professor at the University of Utah.

The advantage of Prialt is that it is 1,000 times more potent than morphine but not addictive like morphine. It is mainly aimed at people suffering from severe, chronic pain who are usually treated with morphine.

The drug is administered by injection into the fluid around the spine. It has become the first non-opioid painkiller that is administered in this method to be approved in Europe.

As many as one in seven people have been known to suffer from chronic pain. Arthritis and back pain are the commonest causes of chronic pain in addition to headache and injury.

While painkillers such as paracetamol or ibuprofen that are administered orally are the first resort those whose pain still persists can be treated with painkillers injected into the spinal fluid, using a pump worn by the patient.

Prialt is a synthetic version of the venom used by the sea snail Conus magus, popularly known as the Magician's Cone Snail, to hunt prey.

As a boy Professor Olivera used to collect the shells of these snails and study them. These two-inch sized snails shoots out a thin worm like tube into fish swimming by. When the venom is injected into the fish it is paralyzed and can be swallowed whole.

A teenager, Michael McIntosh, who started to help with the research soon after leaving school, discovered the venom. Now, 25 years later, he is a research psychiatrist at the University of Utah and still works with Professor Olivera.

On analysis of the venom they identified one peptide that stopped nerve cells from sending signals to the brain. It does this by blocking the calcium channels on the nerves, which transmit pain signals. After the channels are blo cked, calcium is unable to enter the cells, and thereby pain signals are blocked from traveling between nerve cells.

Professor Olivera believes that there are still more secrets to unravel from the sea snail. According to him there are 500 different types of these sea snails with each producing around 100 toxins in its venom. He hopes that drugs use to treat a wide range of conditions, from Parkinson's disease to depression may be derived from them.


'"/>




Related medicine news :

1. Painkillers Do Not Shorten Dying Patients Lives
2. Painkiller Linked to Deaths
3. Canine Painkiller unveiled by Novartis
4. Painkillers may protect against Alzheimers disease
5. Painkillers may raise miscarriage risk
6. Painkillers Increase Risk of Miscarriage
7. In The Habit Of Taking Painkillers For Your Chronic Headache? Time To Switch Over
8. Aspirin Might Counter Side Effects of Cox-2 Painkillers
9. Botox Can Be a Competent Painkiller
10. Painkillers Lead To Liver Failure
11. Study Advocates Use Of Oral Painkillers After Cesarean Section
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... ... 26, 2016 , ... MadgeTech will be showcasing its line of data ... Hampshire at the MadgeTech headquarters. With products sold in more than 100 countries around ... including NASA. , In 2012, NASA strategically set up 17 RHTemp101A MadgeTech ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... Retinal Degeneration” for the Foundation Fighting Blindness, Long Island Chapter on June 4, ... the public. , Dr. Maisel, founder of Retina Group of New York ...
(Date:5/26/2016)... ... ... to provide hair restoration information to the widest possible audience, Dr. Parsa Mohebi is making ... app. Dr. Mohebi, the founder of Parsa Mohebi Hair Restoration, is making all of his ... says, “The positive response to the Snapchat videos we started last month has been overwhelming. ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... of healthcare supply chain solutions, today announced the organization has earned its ISO ... international standards and is compliant with all rules and policies associated with ISO ...
(Date:5/26/2016)... Tampa, Fla. (PRWEB) , ... May 26, 2016 , ... ... Center (AHEC) to host a six-week smoking cessation class starting June 6 at their ... AHEC’s website, http://www.gnahec.org . , Additionally, the Lung Institute has created a free ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... Amarantus BioScience Holdings, Inc. (OTCQX: AMBS), ... Neurology and Orphan Diseases, today announced that President & CEO ... conferences: SeeThru Equity MicroCap Conference   ... City , NY When: Tuesday, May 31 st ... Where: Grand Hyatt Hotel, 109 East 42 nd ...
(Date:5/26/2016)... -- TARE (Transarterial Radio-embolization) Using Yttrium-90 ... Overall Decreased Use of Hospital Resource ... healthcare company, has today announced the publication of ... ISPOR (International Society for Pharmacoeconomics and Outcomes Research), ... yttrium-90 glass microspheres is associated with cost savings ...
(Date:5/25/2016)... 2016 According to a new ... 2D, 4D), by Therapeutic Area (Oncology, Cosmeceutical/Plastic Surgery), by ... Device Manufacturers, Hospitals/ Clinics) - Forecast to 2021", published ... Market for the forecast period of 2016 to 2021. ... by 2021 from USD 117.3 Million in 2016, at ...
Breaking Medicine Technology: